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Abstract The presence of intramyocardial fat may form a
substrate for arrhythmias, and fibrofatty infiltration of the
myocardium has been shown to be associated with sudden
death. Therefore, noninvasive detection could have high
prognostic value. Fat-water–separated imaging in the heart
by MRI is a sensitive means of detecting intramyocardial
fat and characterizing fibrofatty infiltration. It is also useful
in characterizing fatty tumors and delineating epicardial
and/or pericardial fat. Multi-echo methods for fat and water
separation provide a sensitive means of detecting small
concentrations of fat with positive contrast and have a
number of advantages over conventional chemical-shift fat
suppression. Furthermore, fat and water–separated imaging
is useful in resolving artifacts that may arise due to the
presence of fat. Examples of fat-water–separated imaging
of the heart are presented for patients with ischemic and
nonischemic cardiomyopathies, as well as general tissue
classification.
Keywords Cardiac MR.Intramyocardial fat.Fibrofatty.
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Introduction
Fatty infiltration of the myocardium may appear in isolation or
in association with fibrous tissue [1–3]. Intramyocardial fat is
correlated with various cardiomyopathies but is also present to
some degree in normal myocardium. The pathophysiology of
fibrofatty infiltration is not fully understood. Fatty infiltration
of fibrous tissue is observed in imaging studies done by both
CT [4–7]a n dM R I[ 8–11••, 12], and has been reported in a
number of histology studies of samples from endocardial
biopsies as well as autopsies [13–16]. The mechanism of fatty
infiltration, referred to as lipomatous metaplasia, has been
described by several authors [15]. The measurement of
fibrofatty infiltration by imaging studies is relatively new. As
a result, the prevalence and factors that influence lipomatous
metaplasia are largely unknown. The clinical implications are
alsonotestablished,althoughthisisasubjectofactiveresearch.
Histological evidence of fibrofatty infiltration is a hall-
mark of arrhythmogenic right ventricular dysplasia (ARVD),
and is also evident in chronic myocardial infarction (MI) and
other nonischemic cardiomyopathies. The presence of intra-
myocardial fat may form a substrate for arrhythmias [17, 18]
due to the lower electrical conductivity of fat. It has been
shown that fibrofatty infiltration of the myocardium is
associated with sudden death [1], and therefore noninvasive
detection could have high prognostic value. Fat-water–
separated imaging in the heart by MRI [11••, 12, 19••]i sa
sensitive means of detecting intramyocardial fat and charac-
terizing fibrofatty infiltration. It is also useful in character-
izing fatty tumors and delineating epicardial and/or
pericardial fat, and in distinguishing pericardial disease.
In addition to the presence of adipocytes that infiltrate
the myocardium, there is growing interest in the mea-
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DOI 10.1007/s12410-010-9012-1surement of intracellular lipid content within cardiomyo-
cytes. Excessive lipid accumulation within the myocardi-
um is directly cardiotoxic and causes left ventricular
remodeling and dilated cardiomyopathy [20]. Single-
voxel magnetic resonance spectroscopy techniques have
been used to quantify intracellular lipid levels [21–23]a n d
may discriminate between triglycerides in adipocytes and
droplets in the cardiomyocytes based on a small chemical
shift. The role of cardiac steatosis in heart disease is being
s t u d i e di np a t i e n t sw i t hm e t a bolic disorders, such as type
II diabetes mellitus [24–26], with ever increasing impor-
tance due to the obesity epidemic. The potential for using
fat-water–separated imaging techniques for measuring the
low-concentration intracellular lipids is being explored [27].
Conventional approaches to fat and water discrimination
based on fat suppression are commonly used to characterize
masses, but have a reduced ability to characterize myocardial
fatty infiltration due to the poor contrast of microscopic fat and
partial-volumeeffects.Multi-echoDixon-likemethods[28, 29•,
30–34•, 35••] for fat and water separation provide a sensitive
means of detecting small concentrations of fat with improved
contrast. The multi-echo approach to water and fat separation
has a number of advantages over chemical-shift fat suppression:
1) fat has positive contrast; 2) water and fat images can be
acquired in a single acquisition avoiding spatial misregistration;
3) the method is compatible with pre-contrast and late-
enhancement imaging; 4) it is less susceptible to partial-
volume effects and 5) robust in the presence of background
field variation; and 6) it eliminates chemical-shift artifact.
Fat-Water–Separated Imaging Methods
There are a number of approaches for imaging fat and
characterizing tissue content [36], including 1) use of
chemical shift saturation to suppress fat; 2) use of T1-
weighted imaging to detect T1 shortening of fat, which may
be observed as bright signal intensity; and 3) use of multi-
echo methods to reconstruct water- and fat-separated images
based on the difference in resonance frequencies between
water and fat. Multi-echo methods that jointly estimate the
fieldmap, water, and fat images produce excellent discrim-
ination between water and fat. The fat-separated image
provides positive contrast (containing only signal from
lipids), which improves the diagnostic confidence over
conventional chemical shift fat suppression. Limitations of
chemical shift fat suppression and T1 measurements for
cardiac imaging application are previously described [11••].
Dixon’s original method for water and fat separation [28]
acquires two images with different echo times chosen such
that the water and fat are in-phase and opposed-phase,
respectively, and may be combined to obtain separate water
and fat images. This simple method assumes that the water is
exactly on resonance, which limits the performance of water
and fat separation in the presence of B0-field inhomogeneity.
Large, rapid field variation frequently occurs in the chest due
to the geometry of the tissue–air interface. Recent methods
[29•, 30, 32, 35••] for multi-echo Dixon water and fat
separation jointly estimate the fieldmap, water, and fat
images. These methods apply spatial smoothness constraints
Fig. 2 Water and fat-separated images showing common distribu-
tion of fat in and around the heart for a normal subject. The
pericardium is seen in the water image (left); the fat image (right)i s
t h es a m ea st h emiddle image, with window-level set to display
intraatrial fat and interventricular apical fat with lower signal
intensity. AV—atrioventricular
Fig. 1 Dark blood–prepared fat-water–separated images (right) provide better delineation of thin-walled right ventricular myocardium compared
with bright blood images (left)
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proven to be robust for cardiac applications [11••, 19••].
These methods may also be used with arbitrary echo times,
which allows for more flexible protocols.
A number of methods have been proposed to solve this
nonlinear estimation problem. The approach referred to as
iterative decomposition with echo asymmetry and least-
squares (IDEAL) [29•, 30] consists of repeated lineariza-
tions of the original nonlinear problem, alternatively
estimating the water and fat signals and the field map. A
number of refinements have been proposed to incorporate
more complex signal models to account for T2* relaxation
and the multi-peak nature of the fat spectrum [34•]. The
improved models provide more reliable fat classification
and more accurate quantification of fat fraction. A recently
developed joint estimation method for fat-water separation
based on a penalized maximum likelihood formulation may
be efficiently implemented using variable projection (VAR-
PRO) and graph cuts optimization [35••]. This approach has
been applied to cardiac fat-water–separated imaging and has
been shown to perform robustly in the presence of large B0-
field inhomogeneities and at low signal-to-noise ratio (SNR).
Acquisition Protocols
Multi-echo fat-water–separated imaging has been imple-
mented with a variety of sequences and protocols for both
two-dimensional and three-dimensional acquisitions.
Sequences include spoiled gradient recalled echo, turbo
spin-echo, and steady-state free precession (SSFP), and in
specific protocols may include magnetization preparations
such as double inversion recovery (DIR) for dark blood
contrast and inversion recovery (IR) for late enhancement.
Cardiac imaging using multi-echo sequences is typically
performed using an ECG-triggered, segmented acquisition.
Breath-held, cine imaging produces fat-water–separated
images at a number of cardiac phases. Using cine imaging
with continuous radiofrequency drives the magnetization to
steady state, and depending on the readout flip angle, has
T1-weighted contrast, which helps distinguish the myocar-
dial from adjacent blood pool. However, T1-weighted
contrast, if uncorrected, may also lead to overestimation
of fat [37•]. While cine imaging is useful for visualizing
intramyocardial fat and for characterizing suspected masses,
continuous imaging is not compatible with magnetization
preparations such as dark-blood or IR. Single cardiac phase
acquisitions, typically in mid-diastole, may be used in
situations in which magnetization preparation is desired.
Single phase imaging acquires data on the approach to steady
state, and thus has a somewhat higher SNR and reduced T1-
weighting for a given readout flip angle, as compared with
cineimaging.ThereducedT1-weightingimprovesfatfraction
estimates. The reduction in blood pool contrast may be
mitigated by using magnetization preparation.
Fat-water imaging may be performed with and without a
dark blood preparation, depending on the desired blood
pool contrast (Fig. 1). Dark blood DIR-prepared fat-water–
separated imaging provides improved delineation of the
myocardium. The thin right ventricular (RV) myocardium is
difficult to discern in the bright blood images due to lack of
sufficient contrast between RV myocardium and blood.
However, the RV free wall is well depicted in the dark
blood–prepared images. In this example, the measured T1-
weighted contrast of between myocardium and blood
(water image septal region) was 1:1.5, whereas for the
dark blood protocol the contrast was greater than 4:1. This
improves the ability to discern fatty infiltration of the thin-
walled RV myocardium.
Fig. 3 Fat-water–separated images for a patient with pericardial disease with pericardial effusion and thickened pericardial membrane
Fig. 4 Pre-contrast images for a patient with a large anteroseptal
lipoma acquired in a single breath-hold using a multi-echo fat-water–
separated imaging approach provide excellent contrast between water
(left) and fat (right)
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phase-sensitive inversion recovery (PSIR) late enhancement
to provide positive correlation between fibrosis and fat,
which both appear bright post-contrast. The water and fat
images are spatially registered since they are reconstructed
from the same multi-echo dataset. Furthermore, chemical
shift artifacts may be eliminated in reconstruction.
Multi-echo acquisitions are typically performed using an
echo-train readout for improved efficiency. Interleaving
with two or more shots may be used for reduced echo-
spacing, particularly at higher field strength to reduce
potential ambiguities due to higher chemical shift [38].
Echo-train readout using monopolar readout with gradient
flyback is slightly less efficient than bipolar [33] but avoids
potential artifacts. The individual echo time images may be
noisy as a result of large bandwidth, but the fat and water-
separated images have improved SNR due to the effective
signal averaging inherent in the reconstruction. The effective
number of signals averaged approaches the number of
echoes when the echo spacing is chosen judiciously [39•].
Examples of fat-water–separated images are presented
for various clinical cases drawn from our site. Typical
parameters for these examples are 1.5 T, single echo train
acquisition using monopolar readout with gradient flyback,
number of echoes typically 4, bandwidth approximately
1,000 Hz/pixel, and echo spacing on order of 2.2 to 2.5 ms
with TR approximately 10 to 11 ms. Dark blood or IR
preparations were used in specific protocols.
Fat Surrounding and Infiltrating the Heart
The heart is frequently surrounded by fat, both subepicardial
fat within the pericardium, as well as mediastinal fat outside
the pericardium. A large amount of mediastinal/pericardial fat
encasing the heart has been correlated with increased
incidence of coronary artery disease [40]. Fatty infiltration
is associated with various cardiomyopathies, as discussed
later. Intramyocardial fatty infiltration also appears in normal
myocardium [1, 3, 7, 13, 41], with greater prevalence
reported in the RV myocardium than in the left ventricle
[7, 16]. In normal hearts, fat is commonly seen in the
insertion of inferior right ventricle [7] and in the atrioven-
tricular groove [2]. It is also not uncommon to find adipose
tissue in the intraatrial septum (lipomatous hypertrophy)
[42]. These common findings are illustrated in Fig. 2 for a
normal subject without heart disease. An increased amount
of fatty infiltration is also reported in subjects with a large
amount of epicardial fat [14], as the excess adipose tissue
infiltrates the RV myocardium and atrial septum (lipomatous
hypertrophy). Initial findings suggest that there is signifi-
Fig. 5 Patient with chronic myocardial infarction in anteroseptal
region showing slight elevated signal intensity in cine steady-state
free precession (SSFP) image, fatty infiltration on pre-contrast fat-
water–separated images, and fibrofatty infiltration on phase-
sensitive inversion recovery late enhancement fat-water-separated
images
Fig. 6 Fibrofatty infiltration in a patient with nonischemic cardiomyopathy imaged using fat-water-separated imaging pre-contrast (left) and with
late enhancement (right)
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dial infiltration by adipocytes [1, 7, 13]. The border between
the epicardial fat and the myocardium is subject to partial
volume effects, which places a higher demand for improved
spatial resolution to make this distinction clear.
Fat-water separation is useful in anatomical imaging since
it provides excellent contrast between adjacent fat and water
structures, such as myocardium, epicardial fat, pericardium,
andpericardial fat.Italsoeliminatesartifacts suchaschemical
shift, as discussed later. Figure 3,f a t - w a t e r –separated images
for a patient with pericardial disease, shows a thickened
pericardium and discriminates fat structures.
Fat-water imaging has potential for vessel wall imaging.
Fat-water–separated imaging of coronary arteries has been
proposed as an alternative to using conventional chemical
shift fat suppression [38] to provide more uniform contrast.
The coronary arteries are typically surrounded by fat and
may be visualized with good contrast in the individual water
and fat images.
Mass Characterization
The ability of MRI to discriminate between water and fat is
important in tissue characterization. Patients with cardiac
masses are frequently referred for MRI to distinguish between
thrombosis, cancerous tumors, and fatty lipomas, and to
define their detailed morphology. Fat-water–separated imag-
ing provides excellent contrast and is a useful tool in
conjunction with other measures, such as T1 and T2-
weighted, contrastenhanced perfusion, and late enhancement.
Conventional chemical shift fat suppression using DIR
turbo or fast-spin echo readout is a standard method for
characterizing fat. This method is typically performed with
and without fat suppression in two separate breath-holds.
Chemical shift fat suppression has limited performance due
to variation of the off-resonance shift caused by magnetic
field inhomogeneities across the field-of-view. Fat-water–
separated imaging (Fig. 4) may be performed in a single
breath-hold acquisition and provides uniformly good
contrast across the field-of-view.
Ischemic Cardiomyopathy
Conventional viability imaging using late enhancement
does not distinguish fibrosis from fibrofatty infiltration
[5]. Fat-water–separated late enhancement imaging has
recently been introduced [11••, 12] and may be used be
used to directly image fat in chronic MI. A number of
cardiac CT studies have also reported the presence of fat
associated with chronic MI [4–6]. The measurement of
fibrofatty infiltration in chronic MI by imaging studies is
relatively new. As a result, the prevalence and factors that
influence fatty infiltration in chronic MI, as well as the
clinical implications, are largely unknown.
An example of fat-water–separated imaging of chronic
MI in the anteroseptal region is shown in Fig. 5.E l e v a t e d
Fig. 8 Duchenne muscular dystrophy in a canine model with dilated
cardiomyopathy showing diastolic and systolic phases of steady-state
free precession (SSFP) cine images; intramyocardial fat is clearly
evident in pre-contrast fat-water–separated images; fibrofatty infiltra-
tion is clearly evident in phase-sensitive inversion recovery late
enhancement fat-water–separated images
Fig. 7 Fatty infiltration in a patient with Proteus syndrome and with a nonischemic cardiomyopathy shows endocardial fat infiltration in pre-
contrast fat-water–separated images
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image for a region of the MI. This is due to the lower T1 offat
since SSFP images have contrast proportional to √(T2/T1).
An elevated T2 may also appear bright, which may arise in
cases of acute MI or myocarditis and would be difficult to
distinguish. Fatty infiltration is clearly seen in both pre-
contrast fat-water–separated images and PSIR late enhance-
ment fat-water–separated images.
Nonischemic Cardiomyopathy
Fibrofatty infiltration of the myocardium is associated with a
number of nonischemic cardiomyopathies. It is of specific
interesttodistinguish between isolated fat regions and regions
of fibrous fat, and to determine the degree and distribution of
fat and fibrous fat regions. Several studies [1, 2, 13, 15]h a v e
assessed the presence of intramyocardial fat though histo-
logical studies from endocardial biopsy and/or autopsies.
Imaging has the potential for larger-scale studies of
prevalence of intramyocardial fat and correlation with
cardiomyopathy. Imaging must classify tissue as 1) isolated
fatty infiltration versus 2) fibrofatty infiltration, and distin-
guish between 1) endocardial versus 2) epicardial distribu-
tion of infiltration. It may also be important to assess the fat
fraction (ie, percentage of fat in a voxel). High spatial
resolution is important to minimize partial volume effects.
An example of fibrofatty infiltration in a patient with
nonischemic cardiomyopathy is shown in Fig. 6. Fatty
infiltration of the myocardium is seen in both pre-contrast
and late-enhancement fat-water–separated images in the
interventricular septum and anteroseptal regions. The
fibrofatty tissue is subepicardial in distribution in this case.
A second example (Fig. 7) of fatty infiltration in a patient
with nonischemic cardiomyopathy and Proteus syndrome
Fig. 10 Example of a patient referred for suspected coronary artery
disease who exhibited a hyperintense signal in the apical region of
the left ventricular myocardium on conventional late enhancement
that is actually due to intramyocardial fat. Intramyocardial fat
appears as (bright) chronic myocardial infarction on the conven-
tional late-enhancement image; however, pre-contrast water and fat,
as well as water and fat-separated phase-sensitive inversion recovery
late-enhancement images, clearly indicate intramyocardial fat in
apical and intraventricular regions
Fig. 9 Patient with lipophilic disorder with extensive fatty infiltration of both left ventricular and right ventricular myocardium seen in dark
blood–prepared pre-contrast (top row) and late enhancement (bottom row) images
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with Proteus syndrome have a reported increased incidence
of fatty infiltration of skeletal muscle [43].
Progressive cardiomyopathy leading to congestive heart
failure is a common form of death in Duchenne muscular
dystrophy (DMD). The use of late enhancement in cardiac
magnetic resonance (CMR) imaging for assessing fibrosis in
DMD and correlating with left ventricular (LV) function has
recently been reported [44, 45]. Fatty replacement in fibrotic
tissue associated with cardiomyopathy in cases of DMD is
readily observed in histology [46]. The significance and
progression of fatty replacement in DMD is currently
unknown, although inducibility of arrhythmias has been
reported to correlate with fatty infiltration [18]. Fat-water
imaging was used in a pilot study to investigate fibrofatty
infiltration in a canine model with DMD [47]. Fibrofatty
infiltration was observed circumferentially in the left ventri-
cle, emanating from the epicardial surface (Fig. 8). Note that
the fat images pre- and post-contrast are similar with respect
to extent and location of intramyocardial fat. The fibrotic
tissue observed in the late-enhancement water image coin-
cides with the region of fatty infiltration but has greater
transmural extent. Cine functional images (left) acquired with
SSFP show slight hyperenhancement due to the low T1 of
fat. The DMD progression in this case led to dilated
cardiomyopathy with a low ejection fraction on order of 25%.
Fibrofatty infiltration in arrhythmogenic right ventricular
dysplasia/cardiomyopathy (ARVD/C) has been established
through both autopsy/biopsy as well as imaging studies [1,
10, 13, 17], yet the ARVD Taskforce guidelines for
diagnosis by CMR do not include the presence of fat as
criteria [48]. This is due in part to the subjectivity of
interpreting fat based on conventional chemical fat sup-
pression imaging [9, 48]. This may also be due to the
relatively poor contrast of conventional methods, or due to
the limited correlation with late enhancement acquired on
separate breath-holds. Fat-water–separated imaging offers a
new tool with potential for improved reliability [11••]i n
CMR diagnosis of fibrofatty infiltration.
Figure 9 shows an example of a patient with a
lipophilic disorder with extensive fatty infiltration that is
nonischemic in nature. This patient did not meet the
Taskforce criteria for ARVD. Intramyocardial fat appears
diffusely throughout both LV and RV myocardium,
and there is some atypical late enhancement indicating
possible diffuse fibrosis.
Artifact Reduction
Fat-water–separated imaging may ensure correct recogni-
tion of fat and avoid erroneous tissue classification. In one
instance, in SSFP imaging commonly used for cardiac cine,
fat may appear hyperintense and may be confused with
elevated T2 associated with edema, seen for example in
Figs. 5 and 8. With late enhancement imaging, it may be
difficult to discriminate between fibrosis and intramyocar-
dial fat since both have low T1 and appear bright (Fig. 10).
In this case it may be difficult to distinguish fat from MI or
other fibrotic scar tissue. Late enhancement imaging is
widely used for viability imaging of MI and is increasingly
used more generally to characterize atypical fibrosis
associated with nonischemic cardiomyopathies [49]. Using
fat-water–separated late-enhancement imaging it is possible
to distinguish the fibrosis from fat [11••].
A benefit of the multi-echo fat-water–separated imaging
method is the mitigation of the chemical shift artifact. Conven-
tional late enhancement imaging [50] using 140 Hz/pixel has
significant chemical shift artifact in which the fat is displaced
relativetothewater inthereadout directionbyapproximately1.5
pixels. In this case, the epicardial fat may be displaced by as
much as 30% of the diastolic wall thickness. In contrast, the
multi-echo fat-water–separated imaging approach, which uses a
much larger bandwidth, has a sub-pixel shift (typically 0.2 pixel)
and may be completely eliminated in the reconstruction by
applying the known sub-pixel shift to the fat image.
Conclusions
Fat and water–separated imaging provides a sensitive means
of detecting intramyocardial fat with positive signal contrast,
thereby achieving a high degree of confidence, whereas
conventional fat suppression is often difficult to interpret due
to fluctuations in the water signal. The water and fat
separation method may be combined with late-
enhancement imaging to provide a positive correlation
between fibrosis and fat, both acquired simultaneously, and
therefore, spatially registered. This technique may be used to
assess the prognostic value of the presence and amount of
myocardial fat and fibrofatty infiltration. Fat and water–
separated imaging has the potential for quantitative mea-
surement of fat fraction in the heart, which could have
application to metabolic disorders. Furthermore, fat and
water–separated imaging is useful in resolving artifacts that
may arise in other protocols caused by the presence of fat.
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